相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated Anandamide, Enhanced Recall of Fear Extinction, and Attenuated Stress Responses Following Inhibition of Fatty Acid Amide Hydrolase: A Randomized, Controlled Experimental Medicine Trial
Leah M. Mayo et al.
BIOLOGICAL PSYCHIATRY (2020)
Beyond THC and Endocannabinoids
Pal Pacher et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng et al.
ACTA PHARMACEUTICA SINICA B (2020)
Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474
Maria-Joao Bonifacio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice
Marta Kruk-Slomka et al.
MOLECULAR NEUROBIOLOGY (2019)
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro et al.
MOLECULES (2019)
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
Tine van de Donk et al.
PAIN (2019)
Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial
Deepak Cyril D'Souza et al.
LANCET PSYCHIATRY (2019)
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Pal Pacher et al.
NATURE REVIEWS CARDIOLOGY (2018)
A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects
Klaus Schaffler et al.
PAIN MEDICINE (2018)
Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
Andrey Postnov et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Cannabinoids for Treatment of MS Symptoms: State of the Evidence
Jessica Rice et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD
Sharon Fidelman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar et al.
PROGRESS IN LIPID RESEARCH (2018)
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiu et al.
PROGRESS IN NEUROBIOLOGY (2018)
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordonez et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders
Justin S. Cisar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2018)
The selective reversible FAAH inhibitor, SSR411298, restores the development of maladaptive behaviors to acute and chronic stress in rodents
Guy Griebel et al.
SCIENTIFIC REPORTS (2018)
Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders
Ming Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Chemical tools to modulate 2-arachidonoylglycerol biosynthesis
Hui Deng et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2018)
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen et al.
MEDICINAL RESEARCH REVIEWS (2017)
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor
Tomonari Watabiki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
Carlotta Granchi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain
Daniel Bradford et al.
PAIN MEDICINE (2017)
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Andrea Chicca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474
Annelot C. M. van Esbroeck et al.
SCIENCE (2017)
The FAAH inhibitor URB597 suppresses hippocampal maximal dentate after-discharges and restores seizure-induced impairment of short and long-term synaptic plasticity
Roberto Colangeli et al.
SCIENTIFIC REPORTS (2017)
Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
Mauro Maccarrone
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD)
Beatrice Castellani et al.
CHEMICAL COMMUNICATIONS (2017)
Cannabis and Pain: A Clinical Review
Kevin P. Hill et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats
Leigh V. Panlilio et al.
PSYCHOPHARMACOLOGY (2016)
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
V. M. Doenni et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
A calcium-dependent acyltransferase that produces N-acyl phosphatidylethanolamines
Yuji Ogura et al.
NATURE CHEMICAL BIOLOGY (2016)
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
Anne Kerbrat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Endogenous N-acyl taurines regulate skin wound healing
Oscar Sasso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers
Stephen Pawsey et al.
DRUGS IN R&D (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Dissecting the cannabinergic control of behavior: The where matters
Arnau Busquets-Garcia et al.
BIOESSAYS (2015)
Active endocannabinoids are secreted on extracellular membrane vesicles
Martina Gabrielli et al.
EMBO REPORTS (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Preclinical Characterization of the FAAH Inhibitor JNJ-42165279
John M. Keith et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy
Mireille Alhouayek et al.
DRUG DISCOVERY TODAY (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Monoacylglycerol Lipase Inhibition Blocks Chronic Stress-Induced Depressive-Like Behaviors via Activation of mTOR Signaling
Peng Zhong et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Adverse Health Effects of Marijuana Use
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Masanobu Kano
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2014)
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Mireille Alhouayek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
Sudeshna Ghosh et al.
LIFE SCIENCES (2013)
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
Ping Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects
Gai Ling Li et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Giovanni Benard et al.
NATURE NEUROSCIENCE (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
John P. Huggins et al.
PAIN (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer's Disease
Rongqing Chen et al.
CELL REPORTS (2012)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
Kay Ahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis
Niklas Schuelert et al.
PAIN (2011)
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats
Natale R. Sciolino et al.
PHARMACOLOGICAL RESEARCH (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Douglas S. Johnson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Mark A. Ware et al.
ANESTHESIA AND ANALGESIA (2010)
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Mark A. Ware et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
Geoffray Labar et al.
CHEMBIOCHEM (2010)
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Joel E. Schlosburg et al.
NATURE NEUROSCIENCE (2010)
Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications
Natasha T. Snider et al.
PHARMACOLOGICAL REVIEWS (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Kay Ahn et al.
CHEMISTRY & BIOLOGY (2009)
'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
Volker Auwaerter et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain
S. G. Kinsey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
Jonathan Z. Long et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of intracellular carriers for the endocannabinoid anandamide
Martin Kaczocha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Kay Ahn et al.
CHEMICAL REVIEWS (2008)
Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients:: systematic review and meta-analysis
F. C. Machado Rocha et al.
EUROPEAN JOURNAL OF CANCER CARE (2008)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists
G. T. Whiteside et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
A second fatty acid amide hydrolase with variable distribution among placental mammals
Binqing Q. Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Molecular composition of the endocannabinoid system at glutamatergic synapses
István Katona et al.
JOURNAL OF NEUROSCIENCE (2006)
Localization of diacylglycerol lipase-α around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor
T Yoshida et al.
JOURNAL OF NEUROSCIENCE (2006)
The pharmacology of cannabinoid receptors and their ligands: an overview
RG Pertwee
INTERNATIONAL JOURNAL OF OBESITY (2006)
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)
Daniele Piomelli et al.
CNS DRUG REVIEWS (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
DR Blake et al.
RHEUMATOLOGY (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages
YX Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
The endocannabinoid system: Physiology and pharmacology
FR de Fonseca et al.
ALCOHOL AND ALCOHOLISM (2005)
Molecular characterization of a phospholipase D generating anandamide and its congeners
Y Okamoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
AI Gulyas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity
AH Lichtman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
DJ Buggy et al.
PAIN (2003)
The therapeutic potential of cannabis
D Baker et al.
LANCET NEUROLOGY (2003)
Δ9-Tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome:: A 6-week randomized trial
KR Müller-Vahl et al.
JOURNAL OF CLINICAL PSYCHIATRY (2003)
Evidence against the presence of an anandamide transporter
ST Glaser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
15-lipoxygenase metabolism of 2-arachidonylglycerol -: Generation of a peroxisome proliferator-activated receptor α agonist
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
The fatty acid amide hydrolase (FAAH)
DG Deutsch et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Treatment of Tourette's syndrome with Delta(9)-tetrahydrocannabinol (THC): A randomized crossover trial
KR Muller-Vahl et al.
PHARMACOPSYCHIATRY (2002)
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: A pilot study
KA Sieradzan et al.
NEUROLOGY (2001)
Presynaptic specificity of endocannabinoid signaling in the hippocampus
RI Wilson et al.
NEURON (2001)
Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene
M Karlsson et al.
GENE (2001)
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
AC Kreitzer et al.
NEURON (2001)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cannabinoids control spasticity and tremor in a multiple sclerosis model
D Baker et al.
NATURE (2000)
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor -: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
T Sugiura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
